Kabir M, Kodikara S, Hoque M, Shiekh S, Alfehaid J, Basu S
NAR Mol Med. 2025; 2(1):ugaf001.
PMID: 39906285
PMC: 11788920.
DOI: 10.1093/narmme/ugaf001.
Kabir M, Kodikara S, Hoque M, Shiekh S, Alfehaid J, Basu S
bioRxiv. 2024; .
PMID: 39605509
PMC: 11601508.
DOI: 10.1101/2024.11.19.624357.
Liu W, Zhu B, Liu L, Xia X, Jang J, Dickerhoff J
Nucleic Acids Res. 2024; 52(16):9397-9406.
PMID: 39077944
PMC: 11381319.
DOI: 10.1093/nar/gkae649.
Hoque M, Kabir M, Shiekh S, Balci H, Basu S
bioRxiv. 2024; .
PMID: 38559215
PMC: 10979993.
DOI: 10.1101/2024.03.17.585391.
Hernandez Y, Gonzalez J, Garcia R, Aristizabal-Pachon A
Microrna. 2024; 13(2):124-131.
PMID: 38204280
PMC: 11348466.
DOI: 10.2174/0122115366268128231201054005.
Isoform-Directed Control of c-Myc Functions: Understanding the Balance from Proliferation to Growth Arrest.
Kubickova A, De Sanctis J, Hajduch M
Int J Mol Sci. 2023; 24(24).
PMID: 38139353
PMC: 10743581.
DOI: 10.3390/ijms242417524.
Regulation and clinical potential of telomerase reverse transcriptase (TERT/hTERT) in breast cancer.
Yang R, Han Y, Guan X, Hong Y, Meng J, Ding S
Cell Commun Signal. 2023; 21(1):218.
PMID: 37612721
PMC: 10463831.
DOI: 10.1186/s12964-023-01244-8.
Significant structural change in human c-Myc promoter G-quadruplex upon peptide binding in potassium.
Kundu N, Sharma T, Kaur S, Singh M, Kumar V, Sharma U
RSC Adv. 2022; 12(13):7594-7604.
PMID: 35424772
PMC: 8982240.
DOI: 10.1039/d2ra00535b.
A Genome-Wide Investigation of Effects of Aberrant DNA Methylation on the Usage of Alternative Promoters in Hepatocellular Carcinoma.
Dong Y, Liu X, Jiang B, Wei S, Xiang B, Liao R
Front Oncol. 2022; 11:780266.
PMID: 35111672
PMC: 8803206.
DOI: 10.3389/fonc.2021.780266.
Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10.
Yuan C, Bai R, Gao Y, Jiang X, Li S, Sun W
Oxid Med Cell Longev. 2021; 2021:4522210.
PMID: 34925694
PMC: 8672108.
DOI: 10.1155/2021/4522210.
Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer.
Pandya N, Kumar A
Sci Rep. 2021; 11(1):22909.
PMID: 34824301
PMC: 8617303.
DOI: 10.1038/s41598-021-01529-3.
Genome-Wide Analysis of c-MYC-Regulated mRNAs and miRNAs and c-MYC DNA-Binding by Next-Generation Sequencing.
Jackstadt R, Kaller M, Menssen A, Hermeking H
Methods Mol Biol. 2021; 2318:119-160.
PMID: 34019289
DOI: 10.1007/978-1-0716-1476-1_7.
Nuclear localisation of Aurora-A: its regulation and significance for Aurora-A functions in cancer.
Naso F, Boi D, Ascanelli C, Pamfil G, Lindon C, Paiardini A
Oncogene. 2021; 40(23):3917-3928.
PMID: 33981003
PMC: 8195736.
DOI: 10.1038/s41388-021-01766-w.
MYC Up-regulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer.
Kato T, Matsuhashi N, Tomita H, Takahashi T, Iwata Y, Fukada M
In Vivo. 2021; 35(1):203-213.
PMID: 33402467
PMC: 7880764.
DOI: 10.21873/invivo.12249.
FUBP1 and FUBP2 enforce distinct epigenetic setpoints for MYC expression in primary single murine cells.
Zheng Y, Dubois W, Benham C, Batchelor E, Levens D
Commun Biol. 2020; 3(1):545.
PMID: 33005010
PMC: 7530719.
DOI: 10.1038/s42003-020-01264-x.
Identification and Characterization of MAPK Signaling Pathway Genes and Associated lncRNAs in the Ileum of Piglets Infected by Type C.
Luo R, Huang X, Yan Z, Gao X, Wang P, Yang Q
Biomed Res Int. 2020; 2020:8496872.
PMID: 32855971
PMC: 7443001.
DOI: 10.1155/2020/8496872.
A Thermodynamic Perspective on Potential G-Quadruplex Structures as Silencer Elements in the MYC Promoter.
Jana J, Weisz K
Chemistry. 2020; 26(71):17242-17251.
PMID: 32761687
PMC: 7839732.
DOI: 10.1002/chem.202002985.
Transcriptional repression of Myc underlies the tumour suppressor function of AGO1 in .
Zaytseva O, Mitchell N, Guo L, Marshall O, Parsons L, Hannan R
Development. 2020; 147(11).
PMID: 32527935
PMC: 7295588.
DOI: 10.1242/dev.190231.
Quantitative Formation of Monomeric G-Quadruplex DNA from Multimeric Structures of c-Myc Promoter Sequence.
Rauser V, Weinhold E
Chembiochem. 2020; 21(17):2445-2448.
PMID: 32267052
PMC: 7496815.
DOI: 10.1002/cbic.202000159.
N-Terminal Truncated Myb with New Transcriptional Activity Produced Through Use of an Alternative MYB Promoter in Salivary Gland Adenoid Cystic Carcinoma.
Frerich C, Sedam H, Kang H, Mitani Y, El-Naggar A, Ness S
Cancers (Basel). 2019; 12(1).
PMID: 31877778
PMC: 7016764.
DOI: 10.3390/cancers12010045.
